How Many Physicians Have Opted Out of the Medicare Program?

Image
peter doshi :: Article Creator New Research Reports On Financial Entanglements Between FDA Chiefs And The Drug Industry An investigation published by The BMJ today raises concerns about financial entanglements between US Food and Drug Administration (FDA) chiefs and the drug and medical device companies they are responsible for regulating. Regulations prohibit FDA employees from holding financial interests in any FDA "significantly regulated organization" and the FDA says it takes conflicts of interest seriously, but Peter Doshi, senior editor at The BMJ, finds that financial interests with the drug industry are common among its leaders. Doshi reports that nine of the FDA's past 10 commissioners went on to work for the drug industry or serve on the board of directors of a drug company. That includes Margaret Hamburg, who led FDA between 2009 and 2015, but whose story is less well known. Like her colleagues, Margaret Hamburg h

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recomm - EurekAlert

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recommendation for COVID-19 vaccination
Revised content based on updated ACIP recommendations published since October, 2019.
Abstract: http://annals.org/aim/article/doi/10.7326/M20-8080
URL goes live when the embargo lifts

The Advisory Committee on Immunization Practices (ACIP) has released its 2021 Recommended Adult Immunization Schedule that includes changes to several vaccines including influenza, hepatitis A, human papillomavirus (HPV); and the measles, mumps and rubella (MMR) vaccine. The schedule also includes interim recommendations for COVID-19 vaccination. The complete schedule, including changes in the vaccine notes section, is being simultaneously published in Annals of Internal Medicine and on the Centers for Disease Control and Prevention (CDC) web site.

In October 2020, ACIP voted to approve the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2021. Following Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation at its December 12, 2020, emergency meeting for use of Pfizer-BioNTech COVID-19 vaccine in persons age 16 years or older. In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedules. Following Emergency Use Authorization of Moderna COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation at its December 19, 2020, emergency meeting for use of Moderna COVID-19 vaccine in persons age 18 years or older. According to the authors, it is important for all adults to receive recommended immunizations and catch-up vaccines, even when wearing masks and following personal hygiene and social distancing measures. As such, the 2021 schedule includes a special section addressing vaccination during the COVID-19 pandemic.

The schedule, which can be complex and challenging to implement, features revised content, and has been harmonized with the Child and Adolescent Immunization Schedule.

The adult immunization schedule is published annually to consolidate and summarize updates to ACIP recommendations on vaccination of adults and to assist health care providers in implementing current ACIP recommendations. The authors note that physicians should pay careful attention to the details found in the vaccine notes section, as they clarify who needs what vaccine, when, and at what dose.

Media contacts:

For an embargoed PDF please contact Lauren Evans at laevans@acponline.org.

To speak with the lead author, Mark Freedman, DVM, MPH, please contact him directly at fll0@cdc.gov.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Comments

Popular posts from this blog

Observership Program listings for international medical graduates

Vaccination Sites | Covid-19

Vaccination Sites | Covid-19